American Injectables, a Florida-based contract development and manufacturing organisation (CDMO) specialising in sterile injectables, announced on Thursday that it has received US Food and Drug Administration (FDA) approval, ensuring that its injectables meet the stringent regulatory standards needed for patient safety and efficacy.

FDA approval positions American Injectables as a trusted partner for pharmaceutical companies seeking scalable and compliant sterile injectable solutions, the company said.

"Receiving FDA approval not only validates the strength of our manufacturing processes and our team's dedication to quality but also reinforces our commitment to our clients," said Travis Allen, interim CEO of American Injectables. "It enables them to bring life-saving therapies to market faster and with greater confidence."